3 Reasons Jazz Pharmaceuticals Is A Hot Buy Right Now

Jazz Pharmaceuticals (NASDAQ: JAZZ) struggled to start the year, but in the last three months, the stock is up 18.56%. The company, founded in 2003, has grown into a company with more than $2.1 billion in annual revenue and is in the process of building a huge pipeline.

Here are three reasons why Jazz is a hot buy now in the pharmaceutical space.

Continue reading

Source Fool.com